For children and adolescents living with type 1 diabetes, mealtime can sometimes feel overwhelming. Inhaled insulin is a fast-acting insulin option that may offer more flexibility—without an injection at mealtime.
The recent INHALE-1 study explored whether inhaled insulin could help children and adolescents with diabetes manage their blood glucose (blood sugar) as effectively as traditional injected insulin at mealtimes. The inhaled insulin studied was Afrezza, a dry-powder insulin that is breathed in through a small handheld inhaler.
This study showed that children and adolescents had similar blood glucose management results, higher satisfaction for participants, and less weight gain over six months.
.